Baxter Sells Kidney Care Segment to Carlyle for $3.5 Billion in Cash

Baxter Sells Kidney Care Segment to Carlyle for $3.5 Billion in Cash

Baxter International Inc. and funds managed by global investment firm The Carlyle Group announced on August 13 that they have signed a definitive agreement under which Carlyle will acquire the kidney-care unit of Baxter International. The unit will be named Vantive. The deal establishes Vantive as a leading standalone kidney care business backed by Carlyle’s global investment team and resources. Every day, millions of patients, caregivers and healthcare providers rely on Baxter’s portfolio of diagnostic, critical care, kidney care, nutrition, hospital and surgical products used across patient homes, hospitals, physician offices and other sites of care. The company’s products, digital... Read More »
OhioHealth Sells Outreach Laboratory Services Business to Quest Diagnostics

OhioHealth Sells Outreach Laboratory Services Business to Quest Diagnostics

OhioHealth, based in Columbus, Ohio, announced on July 10 that it had signed an agreement to sell certain assets of its outreach laboratory services business to Quest Diagnostics. OhioHealth is a family of not-for-profit hospitals and healthcare facilities serving central Ohio since 1891. Quest Diagnostics provides diagnostic testing information services in the United States and internationally. Quest annually serves one in three adult Americans and half the physicians and hospitals in the United States with approximately 50,000 employees. According to its most recent annual report, Quest Diagnostics generated $9.25 billion in annual revenues during FY 2023, and annual EBITDA of $1.7... Read More »
PE-Backed I-MED Enters U.S. Market With Teleradiology Acquisition

PE-Backed I-MED Enters U.S. Market With Teleradiology Acquisition

Private equity-backed I-MED Radiology Network announced on July 2 that it is entering the U.S. market with the acquisition of San Diego-based teleradiology group StatRad. Founded in 1995, StatRad bills itself as the second largest teleradiology provider in the States. Privately owned by radiologists, StatRad employs more than 90 United States-based physicians performing reads for hundreds of clients and thousands of patients every day, according to its website. I-MED Radiology Network is one of Australia’s leading radiology providers, employing 450 doctors and operating 250 clinics located across Australia. Currently, teleradiology accounts for about 10% of I-MED’s revenue, with its... Read More »
OhioHealth Sells Outreach Laboratory Services Business to Quest Diagnostics

Versant Diagnostics Advances Access to Pathology in the Midwest

Versant Diagnostics has announced the acquisition of Associate Pathologists of Joliet, Ltd., expanding its nationwide network of pathology practices and increasing its presence in the Midwest. Led by its president, pathologist James Urban, M.D., Ph.D., Associate Pathologists of Joliet is a multi-specialty pathology practice based in Joliet, Illinois. Founded in 2021 by Ven Aduana, M.D., Jim Billington and Brian Carr, Versant Diagnostics is an independent physician services company focused on anatomic pathology. Versant Diagnostics provides services for hospitals and physician practices. Versant Diagnostics is focused on advancing digital pathology in anatomic pathology labs and specialty... Read More »
Genomenon Acquires The Jackson Laboratory’s Clinical Knowledgebase 

Genomenon Acquires The Jackson Laboratory’s Clinical Knowledgebase 

Genomenon has announced that it entered into an agreement to acquire Clinical Knowledgebase (CKB) from The Jackson Laboratory (JAX).  CKB is the leading curated variant database used for interpreting complex cancer genomic profiles by some of the world’s premier oncology labs.  Founded in 1929, JAX is an NCI-designated cancer center and an independent 501(c)3 nonprofit research organization with a focus on genetics and genomics research.  Genomenon is a genomics intelligence company dedicated to improving the quality of life of genetic disease and cancer patients by making genomic information actionable. Genomenon combines its genomic expertise with its AI-driven... Read More »
Labcorp to Acquire Bankrupt Genetic Test Maker Invitae for $239 Million

Labcorp to Acquire Bankrupt Genetic Test Maker Invitae for $239 Million

Labcorp announced that it will acquire Invitae Corporation’s assets auctioned through a voluntary bankruptcy protection process. This comes just a few months after the genetic test maker filed for bankruptcy. Labcorp will acquire all of the bankrupt firm’s assets on a going concern basis for $239 million in cash consideration and other non-cash consideration. In February 2024, Invitae filed for voluntary Chapter 11 protection in a U.S. bankruptcy court and said that it intended to pursue a sale process. Invitae’s estimated assets were in the $500 million – $1 billion range, while its liabilities were in the $1 billion – $10 billion range, according to the... Read More »